Fosaprepitant dimeglumine is a salt form of fosaprepitant, a prodrug that is converted to the active antiemetic agent aprepitant in the body. It is administered intravenously as an active pharmaceutical ingredient used in the manufacturing of finished dosage forms.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 265121-04-8
Fosaprepitant
pharmaceutical raw material
Aprepitant
pharmaceutical raw material
Calcium mefolinate
pharmaceutical raw material
N-nitroso-safinamide
pharmaceutical raw material
BLU-945
pharmaceutical raw material
Zotepine
pharmaceutical raw material
[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid;bis((2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol)
VRQHBYGYXDWZDL-OOZCZQCLSA-N
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O